MA52900A - Inhibiteurs à petites molécules de la famille jak de kinases - Google Patents
Inhibiteurs à petites molécules de la famille jak de kinasesInfo
- Publication number
- MA52900A MA52900A MA052900A MA52900A MA52900A MA 52900 A MA52900 A MA 52900A MA 052900 A MA052900 A MA 052900A MA 52900 A MA52900 A MA 52900A MA 52900 A MA52900 A MA 52900A
- Authority
- MA
- Morocco
- Prior art keywords
- kinases
- small molecule
- molecule inhibitors
- jak family
- jak
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862685737P | 2018-06-15 | 2018-06-15 | |
| US201962846290P | 2019-05-10 | 2019-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52900A true MA52900A (fr) | 2021-04-21 |
Family
ID=67766195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052900A MA52900A (fr) | 2018-06-15 | 2019-06-14 | Inhibiteurs à petites molécules de la famille jak de kinases |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20200017498A1 (fr) |
| EP (1) | EP3807277A1 (fr) |
| JP (1) | JP2021528391A (fr) |
| KR (1) | KR20210021342A (fr) |
| CN (1) | CN112313233A (fr) |
| AU (1) | AU2019286641A1 (fr) |
| BR (1) | BR112020024744A2 (fr) |
| CA (1) | CA3101438A1 (fr) |
| CL (1) | CL2020003227A1 (fr) |
| CO (1) | CO2020015396A2 (fr) |
| CR (1) | CR20200603A (fr) |
| EC (1) | ECSP20080817A (fr) |
| IL (1) | IL279314A (fr) |
| JO (1) | JOP20200311A1 (fr) |
| MA (1) | MA52900A (fr) |
| MX (1) | MX2020013688A (fr) |
| NI (1) | NI202000100A (fr) |
| PE (1) | PE20212113A1 (fr) |
| PH (1) | PH12020551984A1 (fr) |
| SG (1) | SG11202011691PA (fr) |
| TW (1) | TW202016110A (fr) |
| UY (1) | UY38262A (fr) |
| WO (1) | WO2019239387A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3555097T2 (ro) | 2016-12-16 | 2022-12-31 | Janssen Pharmaceutica Nv | Compuși imidazo[4,5-d]pirolo[2,3-b]piridină ca inhibitori ai kinazelor Janus |
| JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
| TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Ｊａｋ激酶家族之小分子抑制劑 |
| BR112023018286A2 (pt) * | 2021-03-11 | 2023-10-31 | Janssen Pharmaceutica Nv | Lorpucitinib para uso no tratamento de distúrbios mediados por jak |
| CN113292561A (zh) * | 2021-05-22 | 2021-08-24 | 中国药科大学 | 一种二吡咯并吡啶结构的化合物、制备方法和医药用途 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080747A (en) | 1999-03-05 | 2000-06-27 | Hughes Institute | JAK-3 inhibitors for treating allergic disorders |
| AP1598A (en) | 1999-04-23 | 2006-04-26 | Smithkline Beecham Plc | Polymorph of 5-[4-[2-(N-methyl-N-(2-pyridyl) amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt. |
| AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| DE60319980T2 (de) | 2002-05-31 | 2009-04-16 | Schering Corporation | Xanthin-phosphodiesterase-v-hemmer polymorphe |
| GB0319935D0 (en) | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
| US7737279B2 (en) | 2005-05-10 | 2010-06-15 | Bristol-Myers Squibb Company | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
| AU2006266045A1 (en) | 2005-07-01 | 2007-01-11 | Wyeth | Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same |
| EP2251341A1 (fr) | 2005-07-14 | 2010-11-17 | Astellas Pharma Inc. | Hétérocycles inhibiteurs de Janus kinase-3 |
| JP5071374B2 (ja) | 2005-07-14 | 2012-11-14 | アステラス製薬株式会社 | ヘテロ環ヤヌスキナーゼ３阻害剤 |
| PE20110223A1 (es) | 2008-06-10 | 2011-05-07 | Abbvie Inc | DERIVADOS DE PIRROLO[2,3-e][1,2,4]TRIAZOLO[4,3-a]PIRAZIN, COMO INHIBIDORES DE QUINASA |
| ES2505270T3 (es) | 2009-09-03 | 2014-10-09 | Bristol-Myers Squibb Company | Inhibidores de JAK2 y su uso para el tratamiento de enfermedades mieloproliferativas y cáncer |
| CA2781010A1 (fr) * | 2009-12-01 | 2011-06-09 | Abbott Laboratories | Nouveaux composes tricycliques |
| RS56317B1 (sr) | 2009-12-01 | 2017-12-29 | Abbvie Inc | Nova triciklična jedinjenja |
| TW201129565A (en) | 2010-01-12 | 2011-09-01 | Hoffmann La Roche | Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| WO2011098673A1 (fr) | 2010-02-10 | 2011-08-18 | Genon Biotechnologies Oy | Domaines kinase à double activité et leurs utilisations |
| WO2013007765A1 (fr) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Composés tricycliques fusionnés utilisés en tant qu'inhibiteurs des janus kinases |
| GB201212081D0 (en) | 2012-07-06 | 2012-08-22 | Kalvista Pharmaceuticals Ltd | New polymorph |
| EP2955181B1 (fr) | 2013-02-08 | 2019-10-30 | Nissan Chemical Corporation | Composé pyrrolopyridine tricyclique et inhibiteur de jak |
| EP2924026A1 (fr) | 2014-03-28 | 2015-09-30 | Novartis Tiergesundheit AG | Aminosulfonylméthylcyclohexanes comme inhibiteurs de JAK |
| CA2944433A1 (fr) | 2014-05-14 | 2015-11-19 | Nissan Chemical Industries, Ltd. | Compose tricyclique et inhibiteur de jak |
| EA032953B1 (ru) | 2015-05-28 | 2019-08-30 | ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи | Нафтиридиновые соединения в качестве ингибиторов jak киназы |
| WO2017079639A1 (fr) | 2015-11-04 | 2017-05-11 | Mayo Foundation For Medical Education And Research | Méthodes et matériels pour traiter des maladies auto-immunes |
| JOP20190053A1 (ar) | 2016-09-23 | 2019-03-21 | Novartis Ag | مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط |
| CN109843888B (zh) | 2016-10-24 | 2022-03-01 | 阿斯利康(瑞典)有限公司 | 可用于治疗癌症的6，7，8，9-四氢-3H-吡唑并[4，3-f]异喹啉衍生物 |
| KR102276022B1 (ko) | 2016-12-16 | 2021-07-13 | 일라이 릴리 앤드 캄파니 | 돌연변이체 idh1 및 idh2 억제제로서의 7-페닐에틸아미노-4h-피리미도[4,5-d][1,3]옥사진-2-온 화합물 |
| MX2019006047A (es) | 2016-12-16 | 2019-10-02 | Nestle Sa | Oligosacaridos para generacion de sabor. |
| RU2019121534A (ru) | 2016-12-16 | 2021-01-18 | Басф Се | Пестицидные соединения |
| JOP20190144A1 (ar) * | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
| RS63849B9 (sr) | 2016-12-16 | 2023-06-30 | Pfizer | Agonisti glp-1 receptora i njihova upotreba |
| MD3555097T2 (ro) * | 2016-12-16 | 2022-12-31 | Janssen Pharmaceutica Nv | Compuși imidazo[4,5-d]pirolo[2,3-b]piridină ca inhibitori ai kinazelor Janus |
| WO2018130563A1 (fr) | 2017-01-11 | 2018-07-19 | Leo Pharma A/S | Nouveaux dérivés d'amino-imidazopyridine en tant qu'inhibiteurs de janus kinase et leur utilisation pharmaceutique |
| CN110214140B (zh) | 2017-01-30 | 2022-08-30 | 阿斯利康(瑞典)有限公司 | 雌激素受体调节剂 |
| CN110831600B (zh) | 2017-04-21 | 2023-10-17 | 医肯纳肿瘤学公司 | 吲哚ahr抑制剂和其用途 |
| TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Ｊａｋ激酶家族之小分子抑制劑 |
| WO2020216936A1 (fr) | 2019-04-24 | 2020-10-29 | Janssen Pharmaceutica Nv | Formulations liquides non cliniques d'inhibiteur pan-jak |
-
2019
- 2019-06-13 TW TW108120432A patent/TW202016110A/zh unknown
- 2019-06-14 KR KR1020217000012A patent/KR20210021342A/ko not_active Application Discontinuation
- 2019-06-14 JP JP2020569049A patent/JP2021528391A/ja active Pending
- 2019-06-14 PE PE2020001995A patent/PE20212113A1/es unknown
- 2019-06-14 UY UY0001038262A patent/UY38262A/es unknown
- 2019-06-14 MX MX2020013688A patent/MX2020013688A/es unknown
- 2019-06-14 JO JOP/2020/0311A patent/JOP20200311A1/ar unknown
- 2019-06-14 SG SG11202011691PA patent/SG11202011691PA/en unknown
- 2019-06-14 CA CA3101438A patent/CA3101438A1/fr active Pending
- 2019-06-14 MA MA052900A patent/MA52900A/fr unknown
- 2019-06-14 BR BR112020024744-8A patent/BR112020024744A2/pt not_active Application Discontinuation
- 2019-06-14 EP EP19759032.6A patent/EP3807277A1/fr active Pending
- 2019-06-14 AU AU2019286641A patent/AU2019286641A1/en active Pending
- 2019-06-14 WO PCT/IB2019/055005 patent/WO2019239387A1/fr active Application Filing
- 2019-06-14 CN CN201980040198.7A patent/CN112313233A/zh active Pending
- 2019-06-14 CR CR20200603A patent/CR20200603A/es unknown
- 2019-09-24 US US16/581,081 patent/US20200017498A1/en not_active Abandoned
-
2020
- 2020-01-29 US US16/776,243 patent/US11066406B2/en active Active
- 2020-11-19 PH PH12020551984A patent/PH12020551984A1/en unknown
- 2020-12-09 IL IL279314A patent/IL279314A/en unknown
- 2020-12-09 CO CONC2020/0015396A patent/CO2020015396A2/es unknown
- 2020-12-11 NI NI202000100A patent/NI202000100A/es unknown
- 2020-12-11 CL CL2020003227A patent/CL2020003227A1/es unknown
- 2020-12-14 EC ECSENADI202080817A patent/ECSP20080817A/es unknown
-
2021
- 2021-07-15 US US17/377,249 patent/US11787807B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019239387A1 (fr) | 2019-12-19 |
| JP2021528391A (ja) | 2021-10-21 |
| CR20200603A (es) | 2021-01-20 |
| US11066406B2 (en) | 2021-07-20 |
| MX2020013688A (es) | 2021-02-26 |
| SG11202011691PA (en) | 2020-12-30 |
| CN112313233A (zh) | 2021-02-02 |
| IL279314A (en) | 2021-01-31 |
| US11787807B2 (en) | 2023-10-17 |
| TW202016110A (zh) | 2020-05-01 |
| ECSP20080817A (es) | 2021-01-29 |
| NI202000100A (es) | 2021-06-30 |
| CL2020003227A1 (es) | 2021-05-14 |
| JOP20200311A1 (ar) | 2020-11-30 |
| KR20210021342A (ko) | 2021-02-25 |
| EP3807277A1 (fr) | 2021-04-21 |
| AU2019286641A1 (en) | 2020-12-10 |
| US20200165250A1 (en) | 2020-05-28 |
| PH12020551984A1 (en) | 2021-08-02 |
| US20210340144A1 (en) | 2021-11-04 |
| BR112020024744A2 (pt) | 2021-03-23 |
| US20200017498A1 (en) | 2020-01-16 |
| CO2020015396A2 (es) | 2021-03-08 |
| UY38262A (es) | 2019-12-31 |
| PE20212113A1 (es) | 2021-11-04 |
| CA3101438A1 (fr) | 2019-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201904615B (en) | Small molecule inhibitors of the jak family of kinases | |
| MA52900A (fr) | Inhibiteurs à petites molécules de la famille jak de kinases | |
| DK3512850T3 (da) | Inhibitorer af menin-mll-interaktionen | |
| DK3468966T3 (da) | Inhibitorer af menin-mll-interaktionen | |
| DK3433253T3 (da) | Pyrimidinforbindelse som JAK-kinase-inhibitorer | |
| DK3290418T3 (da) | Janus Kinase (JAK)-hæmmere | |
| DK3833662T3 (da) | Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2- | |
| DK3672965T3 (da) | Pyramidinforbindelse som Jak-kinase-inhibitor | |
| DK3783000T3 (da) | Makrocyklisk kinasehæmmer | |
| DK3596106T3 (da) | Fremgangsmåde til konstruktion af peptidbibliotek | |
| UA41299S (uk) | Корпус настільної посудомийної машини | |
| DK3591122T3 (da) | Hurtigskifter | |
| DK3886857T3 (da) | Montelukast til behandlingen af erosiv håndosteoartritis | |
| JP1648880S (ja) | 双眼鏡 | |
| ES1211013Y (es) | Dispositivo ambientador desatascador automatizado para cespol de fregaderos, lavabos o similares | |
| TWI800634B (zh) | 陶瓷構造體 | |
| DK3790870T3 (da) | Cyclopentanforbindelser | |
| MA50468A (fr) | Posologie à intervalle étendu de natalizumab | |
| MA50430A (fr) | Inhibiteurs à petites molécules de la famille jak des kinases | |
| ITUB20160066A1 (it) | Impianto di selezione di piastrelle ceramiche. | |
| MA52893A (fr) | Esthésiomètre à main | |
| UA38206S (uk) | Комплект елементів викрутки | |
| ES1230199Y (es) | Conjunto integrado de servilletero-papelera con maceteroincorporado | |
| IT201900025195A1 (it) | Procedimento per la preparazione di zabaione | |
| JP1632920S (ja) | 双眼鏡 |